Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by Accountprinceon Jul 11, 2022 3:53pm
239 Views
Post# 34816073

RE:RE:RE:Volume much higher than it appears.

RE:RE:RE:Volume much higher than it appears.RickyBobby - I assume you attended the AGM like the rest of the real shareholders.  So what do you think of holding an AGM (they only happen once a year) and not mentioning the application to the FDA for  Breakthrough Designation for PMX but burying it in the text of the presentation.  This is hugely material and would have been a very positive piece of news.  The timeline confirms it had already happened as of the AGM as does the AGM presentation.  So why - in your expert opinion - didn't management take the time to bring this forward and explicitly make sure all their shareholders were aware of it?  Many have been around for years and years waiting for this - some as long as 18 years and some more than that.  Could have moved the long suffering share price substantially upwards.

Hmmmmmmm?  
<< Previous
Bullboard Posts
Next >>